SCHEMBL19852037

SCHEMBL19852037

c1ccc(CCN2CC3CC(C2)N(c2ccccc2)C3)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
OPRM1 P35372 4/20 0.50
OPRD1 P41143 2/20 0.50
OPRK1 P41145 2/20 0.50
HTR1A P08908 1/20 0.46
DRD2 P14416 1/20 0.46
MAPT P10636 1/20 0.45
SLC6A3 Q01959 2/20 0.44
GBA1 P04062 1/20 0.43
HRH3 Q9Y5N1 1/20 0.42
SIGMAR1 Q99720 1/20 0.42
ADRA2A P08913 1/20 0.42
AR P10275 1/20 0.42
PTGS1 P23219 1/20 0.42
SLC6A2 P23975 1/20 0.42
HTR2A P28223 1/20 0.42
ADRA1A P35348 1/20 0.42
PTGS2 P35354 1/20 0.42
KCNH2 Q12809 1/20 0.42
SCN5A Q14524 1/20 0.42
ACHE P22303 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21071992 1.00 OPRM1 (0.50) OPRM1OPRD1OPRK1HTR1ADRD2
SCHEMBL21072109 0.76 DRD3 (0.46) OPRM1OPRD1OPRK1HTR1ADRD2
SCHEMBL19852248 0.76 DRD3 (0.46) OPRM1OPRD1OPRK1HTR1ADRD2
SCHEMBL21071714 0.75 OPRM1 (0.82) OPRM1OPRD1OPRK1HTR1ADRD2
SCHEMBL21142567 0.75 OPRM1 (0.82) OPRM1OPRD1OPRK1HTR1ADRD2
SCHEMBL5041464 0.73 CHRNB2 (0.55) OPRM1
SCHEMBL31119577 0.73 CHRNB2 (0.45) MAPTSLC6A3SIGMAR1SLC6A2
SCHEMBL7523207 0.72 SLC6A3 (0.57) HTR1ADRD2SLC6A3GBA1HRH3
SCHEMBL9585610 0.72 SLC6A3 (0.49) OPRM1OPRD1HTR1ADRD2SLC6A3
SCHEMBL7003079 0.71 SLC6A3 (0.61) HTR1ADRD2SLC6A3GBA1HRH3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018026371-A1 DUAL NAV1.2/5HT2A INHIBITORS FOR TREATING CNS DISORDERS SUNOVION PHARMACEUTICALS INC. (US) 2018-02-08 WO disclosed